glutathione pathway to triple negative cancer Excessive intake contributes chemotherapy resistance in breast cancer: a propensity score matching analysis | World Journal of Surgical Oncology GSTP1 Is a Driver of
GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC Frontiers Oxidative stress and antioxidants in breast cancer: a double edged sword NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene Recent advances in targeted strategies for triple negative breast cancer Journal of Hematology & Oncology Springer Nature Link Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





